Technology
Health
Medical

Integra LifeSciences

$55.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.04 (-3.56%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell IART and other stocks, options, ETFs, and crypto commission-free!

About

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. Read More The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Plainsboro, NJ.

Employees
4,500
Headquarters
Plainsboro, New Jersey
Founded
1989
Market Cap
4.71B
Price-Earnings Ratio
76.21
Dividend Yield
0.00
Average Volume
679.81K
High Today
$57.15
Low Today
$55.24
Open Price
$57.06
Volume
90.68K
52 Week High
$67.50
52 Week Low
$42.14

Collections

Technology
Health
Medical
US
North America

News

Simply Wall StMar 20

Should You Worry About Integra LifeSciences Holdings Corporation’s (NASDAQ:IART) CEO Pay?

Pete Arduini has been the CEO of Integra LifeSciences Holdings Corporation (NASDAQ:IART) since 2012. First, this article will compare CEO compensation with compensation at similar sized companies.

5
TradingNewsNowMar 13

Latest Valuation: Integra LifeSciences Corporation (NASDAQ: IART)

Integra LifeSciences Corporation is part of the healthcare sector and is in the medical devices industry. The company CEO is Peter J. Arduini. Integra Lifesciences Corp is engaged in development, manufacturing, and marketing of product lines from its technology for applications ranging from burn and deep tissue wounds to repair of dura mater in the brain to repair of nerve and tendon. Previous Intraday Trading Performance: The IART stock showed a previous change of 0.49% with an open at 55.03 and a close ...

6
MarketBeatMar 10

Stock Price, News, & Analysis for Integra Lifesciences

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.

0

Earnings

$0.45
$0.52
$0.58
$0.65
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 24, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.